<SEC-DOCUMENT>0001193125-12-043879.txt : 20120207
<SEC-HEADER>0001193125-12-043879.hdr.sgml : 20120207
<ACCEPTANCE-DATETIME>20120207165123
ACCESSION NUMBER:		0001193125-12-043879
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20120203
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120207
DATE AS OF CHANGE:		20120207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30489
		FILM NUMBER:		12578469

	BUSINESS ADDRESS:	
		STREET 1:		10813 S. RIVER FRONT PARKWAY
		STREET 2:		STE. 500
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		858-312-8000

	MAIL ADDRESS:	
		STREET 1:		10813 S. RIVER FRONT PARKWAY
		STREET 2:		STE. 500
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d296993d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Pursuant to Section&nbsp;13 or 15(d) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of
1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of earliest event reported): February&nbsp;3, 2012 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>Lifevantage Corporation </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Colorado</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>000-30489</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>90-0224471</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other Jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>of Incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>File Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9815 S. Monroe Street, Suite 100, Sandy, UT</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>84070</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of Principal Executive Offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Zip Code)</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code: (801)&nbsp;432-9000 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain
Officers; Compensatory Arrangements of Certain Officers. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(e) On February&nbsp;3, 2012, in connection with its annual
review of the management team&#146;s compensation packages, the Company&#146;s Board of Directors approved the recommendation of the Compensation Committee with respect to an increase of the annual base salary of Carrie E. McQueen, the
Company&#146;s Chief Financial Officer, Secretary and Treasurer to $288,500, effective as of January&nbsp;16, 2012. The Board of Directors retains the discretion to further adjust Ms.&nbsp;McQueen&#146;s annual base salary at any time.
Ms.&nbsp;McQueen will also be eligible under the Company&#146;s Annual Incentive Plan to earn a target performance bonus for fiscal year 2012 of $144,250, less all applicable withholdings and deductions. Such bonus opportunity shall be based on the
achievement of Board specified performance goals and subject to the terms of the Company&#146;s Annual Incentive Plan </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;8.01.
Other Events </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On February&nbsp;7, 2012, Lifevantage Corporation issued a press release announcing, among other things, that
it will release financial results for the second quarter ended December&nbsp;31, 2011, after the market closes on Tuesday, February&nbsp;14, 2012. A copy of the press release announcing this news is attached as Exhibit 99.1 and incorporated by
reference herein. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01. Financial Statements and Exhibits </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Exhibits </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:28pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>


<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press release issued on February 7, 2012.</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-2-
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dated: February&nbsp;7, 2012</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Lifevantage Corporation</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Carrie E. McQueen</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Carrie E. McQueen</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer, Secretary &amp; Treasurer</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">-3-
</FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d296993dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g296993g19k54.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>LifeVantage to Announce Fiscal Second Quarter 2012 Results on February&nbsp;14, 2012 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">Salt Lake City, UT &#150; February&nbsp;7, 2012 &#150; LifeVantage Corporation (OTCBB:LFVN), maker of Protandim<FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, the Nrf2 Synergizer&#153; patented dietary supplement, announced today it will release financial results for the
second quarter ended December&nbsp;31, 2011, after the market closes on Tuesday, February&nbsp;14, 2012. The Company will hold an investor conference call at 2:30 p.m. Mountain time (4:30 p.m. Eastern time). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investors interested in participating in the live call can dial (877)&nbsp;604-9665 from the U.S. International callers can dial (719)&nbsp;325-4886. A
telephone replay will be available approximately two hours after the call concludes and will be available through Thursday, February&nbsp;16, 2012, by dialing (877)&nbsp;870-5176 from the U.S., or (858)&nbsp;384-5517 from international locations,
and entering confirmation code 2407254. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">There also will be a simultaneous, live webcast available on the Investor Relations section of the
Company&#146;s web site at http://investor.lifevantage.com/events.cfm. The webcast will be archived for 30 days. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">To receive email alerts
regarding LifeVantage&#146;s upcoming investor events, stock information, SEC filings, or Company issued press releases, please visit the Company&#146;s investor relations page and sign up for Email Subscription Alerts:
<U>http://investor.lifevantage.com/alerts.cfm</U>. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About LifeVantage Corporation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">LifeVantage, (OTCBB:LFVN), maker of Protandim<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, the Nrf2 Synergizer&#153; patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to
transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level. The Company was founded in 2003 with headquarters in Salt Lake City, UT and operations in San Diego, CA. For
more information, visit www.LifeVantage.com. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investor Relations Contact: </B> </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Cindy England (801)&nbsp;432-9036 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director of Investor Relations </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">-or- </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Mills (310)&nbsp;954-1105 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Managing Director, ICR, LLC </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g296993g19k54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g296993g19k54.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`-P#L`P$1``(1`0,1`?_$`,(```$"!P$`````````
M``````@)"@$"`P0%!@<``0`!!0$!```````````````%``(#!`8'`1````4#
M`P,"`P4%!0(/`````0(#!`41!@<`$@@A$PDQ02(4"E%A<3(5@9%"(Q;PH=%2
M%[$:LC-#4R0T)365I=486#DZ$0`!`P($`P0'!@('!`L````!$0(#``0A,1(%
M05$&87$B$X&1H=$R%`>QP4)28B/A%?!R@J*RXD.2,[,T\<)C@Y.CPR0E%C;_
MV@`,`P$``A$#$0`_`'^YAH`B']NNEWTCV52WF^[3P&FHGF09(E3@;[1#7A'*
MO6N)"NJF90P!4*>OV:@E<YA\.53Q@.&-6B[TS<ACK&(0A!`QE#AL)VOSF$!$
MU/Y20")A&GIJQ;-$^`75_1/;5.\G-L-6&G^-(4\A?J-?'#QQR'+8SN2>RS?-
MP02RK26<XML",NN&9.T#"DNW6?NKOA3%5;JAM.`)C0>FM=;=#;W?VWS%F80"
MJ:G$9?V>=9>;K/;+.X\FZ\TE!\+1Q[=7W4ISPYYC8>YSX0AN0>"'LZ]QY<,E
M*Q4>:YH9*#F4'T(Z.QDF[Q@A(2:9#I.DQ#HJ/IH!?[/?;1/\MN!89"%&@J,"
MGVBCMCND.[1>;8`@8?&$X+P7A14E4J(@-/3^WOH9I>'G4GE\.?;1)I).D_$,
MZB90`#[_`+NNG%KS\--?+'&4<M>`YA$/0`]ZUU7/GB0`Z="XTYLD;A@JU$3#
M["7]^K('?3'%_P"%*B!OM$O[](BO6EY^)%J43C4?\!TS3)V5[YL8PQJ.\/?U
M_#2TR=E>>='VU(*OQ@7I00#\?6FI`PZ5=G4#KE)0P?"1]]5!.%:5#43W!K5X
MU=`4+4G<$!H(E^[7C)&O*<:A;YBN5$#5JFJL8A!,7:(E#=M]=U/4H=?40]-.
MD5H\.=2V_P"XNOV58M)EF_7<MF3MFZ58N1:OR-ER+G9K;!5!NY*0?Y2QDP]!
MZZDEC>QK2T(O.F121OU$_A%93?\`VIJ!)OTTWS6=M0[@_9_=KS]_]->>:WMJ
M(&J'J%=3`(%=RISB4!'&O`8WN)=-:0ZFASUQ1*B!J^X>OVZ\<2'(.53)@M>$
M]/2@_P!_^S3FAQS2HW/:W-:D[GV_AZ#ZZ3V2:?VTU=M,\^,%"M>$Y@`P_#TI
M2FH(&W9>DVC3V4^9XCBUM5:ID54,(UV^_H`_;JXYC1DM4HKB9Y.K2E5!.:G2
ME?P_?J)[7_@2KL<C7#Q9U5]OOII8^FGX9\*QLS+QD%&N9:9?LHN-:`D+I_(.
MF[)FW*LNFW3,NZ=*)((E,LJ4H"8P5$0#U$-211.G>(F`EQX>A:BGG;;Q&9_P
MM]Z5@K=O6U+O!Z-JW##W$$>=-)\:%DF4D1FHL"HI%<':+JE3$X(F$`K4::;/
M:S6SO&$[Z\@NH;EJL*^JMA$1^T?WCIT1U-QI7`('ARK7+AO:U;2107NB>B;?
M;NUSM6:\S(LHU%VNFD=8Z3=1VX1*H<$R"--.MK62]8?*&I"53AP6H[N\98O:
MV3#4G+OH+O(5F->Q.!W)O*>.YMJ_?PV);R+"2T4[2=-V<BK&N6)7;9VW4.F9
M5HHKN$2"/IT'1OINR:=V9;SC!7'E\+21[:!=379.U&:+B&\N+A3!_P`'_C:P
MIY$,HYBD>1M_/8>U[)B$Y%2)C[F"VI:[+IFG:9QE7LP=TW77306<=PQ!W4`*
M:[3U-OVX],VORFUM)3'X-8\3=1*]_NKC73NVP=0W`FOW-#"4Q=I*!R(.7VT_
M\X#<1</<&./41@'"ET/+JL&-NBZ9N+E)&23F'QWMP2B\G(LU7R#EX1;Y-PJ)
M`$5*T#J`:X3N6\;AO=V;B_"2A0/!HXDY=YKN.W[?:;+;!EB?V\%QU<$^RN]W
MMGC"^/W:+"]LGV5;#Y0BBA&,M<4:V>`5+\^YN+@52F+]@A7[M4X=FW;<)"UD
M;GM8AP!&>&:!:MOWW;[0"29R.?AFWAV+6ZVQ>MKWI$H3=GW##W-$KD3.B_A)
M)E)-S@?TJ9NN<4S4]C``ZAW"WOMN&B1CFO"!""ONJU:W5AN1\R-P3^L._@3S
MK/J2""8IHF53,Y7`PMT"+-P67*3\YT$S*E,H1.OQ"'I35:SCN)P9I!X!G@1]
MU-N9[>"1L8^)QPQ'OJJ"VZNT3"`"8-W\([:>@UZUKT_#3K@NC*5;@TO"YU*J
MOVB%4$#&3H)CJ@8A$TB`(@8ZAU3I@4I:==/MUD&.5-G(C4FH)/FJY!41=MUD
MP(*@JI+)*H]LHB!C]XAC)4`0Z_%J4Q70*!$)PP/N6J_S-KQ.(SQ'OK#FNNV@
M<@S-<D"1T<Y4DVQIJ-!P=82B;LE0^9[H*@4M:"4/4-.^7O1^'+])]U>BZLDQ
M/M'OK+H.2.``R8B;XA3^P=Q:B8`J(`:@!6H5"@ZAD=/$_P`J0>+L%/;%!<`7
M##X<L^7<M2@];G.9,JZ:BQ:`=%-9-19,P@(@11-,YC)&$"C^:@:>R$RM!=EZ
M13);R.#PC[C]]:^M>UI$<E9#=-N?J'=!,L:,_$%?F4`?B3*U.]*J)R!U$*>V
MFR6?DN:C7`EX&(/NKRVNQ,U[B0F@\N'I6ME[Q>FT=XCM,&T0$-HA4#UW4$GW
MA75KRUQ.`JLV[`:[FHY4@KX=[\FY?.?E78W9=;B0;P7,UNPM\DQ)&,WCXM:T
MW)OE8P':A>VW(YZ&`H`6H?=H_O=H\1L\L$K&['/%1GZ*SNT[@#<N:\@`O8/0
M=2_=W4O(D\0<%,9LZ0="0:'*V<MUS)C2M#]M0Q2B(??K)&WN1F@]!]U;/S[;
MG[1[ZI/)N(C4R*R4M&QJ2AC$34D'S5B50P>Q!=*I5$?;2%K<G$#V'W5YY]OS
M'K'OKS"7CI5(5X^09/4:B`JLGC9XD!B]#E%1FJN2I!Z#UI75J2%XB#2/$@X$
M56CN&/>YH."E,JR`FH4#BH&T?RB!J[A$*@!:=!J&JL,#VO4Y59D<UC5K!2ER
M0,+V_P!:G(B',J'\LDK*,8\Q^O\`#\VX2*;]@ZL2V%Q<'S(6DQC!0"1[!5-F
MZ6T/@F*/)YM&'I(JY9S<6^;?.QTI'R+,:@+Q@[0?-2F`Q"@0R[4ZJ8"83].M
M.FJ<EK>6^)"'@H/NJ]'=VMQ@TA.\>^KI)VFZ`11616`ICE.*"R2P)G((!L4%
M%0X%,(#6GK3UU";FZA/[HP/Z:?HMI,B"AYU9.IJ,8)*+OY1DQ;(J%36</G23
M)NF)QVD$5W9D4A*900+T$1J(:LQRW$N+![*3Y;9@TDCUCWU2C;BA)BIH><B)
M8B1A!8T7*L)$$#%'J57Y-PN)34#TZCJRZ.YTEY"-`Y'W57^>LVN$0/B=AFWC
M_:K-%<)G)O,!D@$ISE!0``3$3"IC@`"/2@?CJ!MPU/$JU[):JI:B]]7]0V;O
M;;7]E*_[-/7C7J8)2/\`Y]'[^,\0_-)]&/'T>_;V=8)FSR->N(YZ@<V9L;IB
M9!ZU51<(&$AQ`1*8!$HB'H.M3T5;MNNJ+2W=\+GN[,HWGAW5F>LI70=-74C2
MC@UF*+G(P9>FD:/I*+CN:X\:<SEKBG)V;,TO_$QXL9:9?2IF35W"WF#E(IGC
ME<4P.HW*(A[TUH>O+*&RNVQQENAS2N*XXIGE62Z)W*YNF(X.*'\HYM'`4\)J
M`^@UUS2-S6/+5"+759&%S<0::)_5J7)<=MX#XJ+6_<$W``YS%-MGJD')/XU9
MR@6U)5P5)0[!5(ZA2G2#I]NNC_3"QBO6W+'H2`4"E?B`X5S'ZD7\]G)"Y@(:
MK<4"?"XYFMEX\RTS,?3'W._F)-]+R:F(LCI+2,BY</7:Z2+IZ1OWG;HZBRQB
ME*4*F,(UTRXB-CUA)%&/AU(,SD>>-2VTS;_I-LLQQ.A2<`F"8C#.FG?CUX-<
MQ>:C^^8[B5+.(9:R&D8-WG9W2K:R[L9(B35L*JY7;,K@B)UBF_,-`#78]VWG
M:]LLO/W/4)2"-(*.^%1@HS&1XUR+:;6_NKP6=BTNCU`AVDN:I=CB`>.:Y4YK
MR5R@Y$>$OQ.8_P`&Y%FD)3F-DVZ<AI0#QW-)W%(V];LG,+JFO+YURNX3.W8)
M*BB41,8I3%J`5ZZY2ZVM^I=T-S9QR&U8JYN!))=B6KD$-=2;N4W3M@(KP_N.
M`P``.6G`.3C20_%/Q`^1GR=V<ORFN_*#R!87D9[/VI<F19^9,YN7YP3$*XB8
MPB3[Y5@\,2I#]M-$Q!`2CK:7G4FU=.,@M6ZO.>\ZT(<C<PJG#T8GNK)66UWO
M4TES.X:8F1@LU`M4_"0"!B<,JLL"<CN;W@VYLQ>*,W3,\XQP_?QQ;YM.1?N)
M^V)FUY58C4;HM@S\ZR**K$`[A.P*9@$1"G00"'J!FV;]MS;J!)'EK2$<K@N)
MP:21F%%.V)^X[/?NMY"&,!<%+4&&`Q<.RG2GE_O;(=A8PXG^07C_`'M<K"T\
M27U8=QWA!0<F\""NC%-]N(MV\<S+!FL=@\:I,9(VXRP"F7IUI37,MK>Z,R[9
M*Q_FS($3[1G6_P!P@=+(S<V.860G42"N6'##UH*7<LF\8;(%E6U?%LO$7,#>
M$+%W'!KHF36*+&78-7K,XF;BHG\*1C`80$0`U0UFMQMG0R&"0'S&%"JXE3]R
M5J]JO!-'Y@(##W)D*3/\RW)Z;XX\*+Q+8$DY1RSEJ3A,38N)'"(29KIO1Z#1
MNX9-TZ.E3LB'`ZFPIA(3XC``:(;'8F20.</"._CE]]5-YO=#2UA5QY(>5<MN
M_@=R_O'B5Q7X^XTY77%AQQ"6U'+\D+T37=2%^7*_DX9B[F&<+,+,7Z[<R,FJ
MN0H%61`I=OI[$QO5FV=SG,U2,.D$:20&X<3@57T)0G^1W3XVNU`->-14.&>/
M`8_]-<@=^`''2D.L[9\Q^69<@J;GB60'N2+@6=JS`$*BE(FCPF3MR%*8"AM*
MG0"E]--;U$[S$>P:5R!Q]N%>GIZ32H>-7:"GO]E97QQ9ZY-X3Y49,\:W,*]E
M,GW'9]M(Y)P1E9VDF$]=^/\`OD26;2KU-NV%ZNR[0]Q0^XX;J&-UIJQ=V45]
MMIWF(!@#])#L"[(8`8$J5YX&E%?R;6?Y6':GH7>%"@/?CP[L:3V0SIS4RQY&
M.>'!_CS>%T6_*Y(OZQY>7R$]61=I82PW;[";CKI6M5=V9T2+EY=]*MC)E1*"
MIQ)4/35J>TM;&%LDI;I:`1B<\!@O?Z*&V]Y<7\Q:T.53P]/#NH\9SZ?G"KV!
M4FC<E.4Y,T*M15)EM'*%WG<)3@HG%)^,'^O&C015>;1.4K<1V^H`&@TFX_-R
MM;(&^4QX<`7([#V9=J5H)[22TLS+$ID<""C=7!<LT]"UM/BDY+\AX',6</'7
MR[G0O/,7'MJC<5BY'=`B1U?^*G3M!C&R+E8A$%)!\DDJ43G$@B!^AC:L;G:Q
M&-MW;8PN:I(4C$^%3D#]HH%MM[)J?!<82AV3D!P&.&?NI-7AQX[F/-7D]Y-K
MD<\B.06$C63RO4@@@\3W8K"Q4T60@G3]-\]1;2;=-1P1(VTN\`$HZN;MN#K1
MD36@%5.)Y`>^H]HLC<W#]9+<0,N9.?+`4X?XA\(#</+$OVV+?SWE7+\A>CM>
M1CY_+<HI<<A!.0:]E!)F9=5]W&R2I`$0$!#[M`I-V%PYGG-&AI)*'/[*UG\D
M+5#7-QYK_&DXX[POYBSB]E+PYI\YL\WE/2<LY=H6ICNZ7UEV9#M1.(II-FT"
MM`)D`""`4*F/0-6CO36M#8&'NP'J1:B.RX^-[/6:&3D7Q,Y-^(>-:<M.)/(7
M+>6\&V)-,7^<,*93GI"[4$;"%P0TI*V^:65D7*@H-S&$1*J4X>^IVF/<&B-[
M4G(5,3WIR(XKZ*#0S/M;J0%W[+'D*0`.S$X'(ICWI2M7+CR06+Q\X,VSRVMY
M`D_(Y5MRS$L+6<W(5R:Y;UR'%-)"$CTFZ9NZL5B9YM6#KLV4'5.VVY_S)MY@
MB8DE04R`].=%+W<6&W\R)[2<40@CM]5)SXA\1>=>9]L1^>/(YR/R^%_7PD6?
M985QK=\M:EI61$R!"O8Z)4+"N88@R#8B_P`=!.```%$U0H!9V_#:A\G9`."J
M?R@Y)S7#&@-OL<F\`W=R=)!("@@D#$%,,,<ZN\C<+^5?BT9..0G$?-^1LX8-
MM5)5QEOC3DN4>74[=V61$WS4C9;M^,@]++1?<.8P).4U3EI3<`#2:+=K3=7-
MBN8SY_#'C^DY\`M,DVRYV\%\;VF,=A]JA.-;=X,.4A\A<..47('(M[3SRTHK
MD5EJYBR%U/%UG=K6:RBH.5;VZFL^4.8GZ:J95L5+<.TP[?4-5M\MH-4+8FD2
M.)P)..6/=F?15C:9KI[Y/,<WR`PXH``>2IGV5Q?$>*>1_FRN6Z.0.7<LY%P?
MP63N.0A,(8KQU+N[3N#(47!N5T#W5-RL*JTD%&+YVD42F,Z$#;!*4.@AIDTM
MC86[6,1UP0,RG'-Q^[/L2O8["ZO;C4YP\E>`/J']/;6Q9[\5N7^!EJ3')SQR
M9YS(%WXR2"[KHP=D&[)6];)OVW8LHR4\GV;C=S1AE5V310";*&`3>H=-3[5N
M]M<N=8W0;IE!:"N"D@8KB$S!]6-1[ET[-;EMW`X.,9#B$*^%3AS-+0\$^6-N
M\UN,6.>0-NHE27N9L[:W)%',4OZ%=\08&-QP:J0J&,W,T<FZIFH)0$*@%=9K
M?]KBL;A\+7,T!""I(0]I[JT^P[K+>Q`S!X><$(`*HN7JHVOX/0/R^G2GIZ?9
M30E/"G!*-\:1V\_]!\0'-6OI_1V/J^W3_6G&NMS].`T]:V`?\.M__"DK(]=*
M.E+O3FD?_%CI%SZ0L1#&'-@"^AK\Q`!J![?HE]!U_9HY]38+<;JWRT0MQ0KQ
M/;6(^G%U>",M>7)CP_4SLIXX!2E]*?V_;KE<C+=C27`>O^-=FF?.Z-6JO=30
M;ZN?X>/_`!+`.E,VW!_?9TSKIWTE;Y&XRDY:!_C;7+/JLX3;;$T8^/\`]-U;
M=QE__,%<@_;B3(8_^<.M2W[P[ZB3/'YY/\)IEBTCH)H/%L?VMH0_I&USA>O+
M`.O:&'M@##[=P#L#``_?M#17ZJ0Z[@S9E&#^XE!?IA+H`C*IJ/\`CH4OJJKR
MEWO/_%5N22JQ[=LO"D&,1'F3JR>,Y>9&2F"G4VUJN90R8AN"NB?TJ<R+;'L!
M0^85_P!FF_4YQDO&J"3IPYKK*40.&_J1\MX7Q)C7%%E<'I-2V\;6+$6M`BC&
M3C-!PQMY@BS2>I;I%-)5-PFB!B@0*"(UUG-RZ8CW#>9W3/``TN!<HX`($08"
MKNV;S+:;5$V-KG%7#PI^8E3G25GE@\A5^>3F0Q9,R_&*XL>W%C=M(Q;F990D
MP=U/P\F07+1-PJD=PJJ$<Y6-M"H`4=:+:-F@V:)SHY8\2N?,`8+PP6@NY[G/
M?2C7'(HPR[>P4]FX#8Y-RJ\+.(<397CSKKWWQUE;"D6,HBLC(-G$6M-P=M&6
M2<!W45&B,<T4+N`!H4/8=<XW+=3:=4-OV.5PE:<PA&EJ^G.ND;9:&?IJ:U+2
MTNB<,0?S$Y>JL?X,,M7-,<59/C7DITH;+G#N^+IP;>+5\&R2=Q<!(J*6E,&3
M/146LE$N"]I2FTY2]--ZD8R69M\W_6*KVYKRR(]51]/DM:ZV/X`<^P`)SKB/
M(%@;F[YD,+X);'-,X<X46$.7\F@F)%HL<L7(Y#^E(Q59(#)?.L(Q'=LJ!R@/
M77L$G\OVLW3BCWJG!.`S]?II.89MR^6`5"/L7^%%'SW\DDQQ]R/9_%_C?B>5
MSWRJR(S6DXFRHD558FRV*AQ;(SMY.VBS<L?'&.434563#:7[-5=EV*SE6YN'
M-;&23B47(DDD^[*K6[;[?1)#`'D@!J``HBA!A0RHS/U#<JV&XV<+Q,BD1*5Q
M_1[HCI9XF0"ANCR20729LJL7:(&,0XAN&GJ&I;NTV2"X#6%A)/`GVXX4RUO]
MYG@U/$@"#-H'W4(6)+\YAW9YKN)SOF3B.V\27TA@C+$1$+V2[.\B+NATB,#*
M*+KFE)<1(FX$![8J%`@TZ!7KHKL0?_5@+?3Y?S#LBN.@^VLY$9AU(YTZ^9\L
M,PF&JC.\8]MQKKRB^6^[UR-W4^PNS$UNMWI2%*HSC99C<<A(,]P``T%:,1$/
MPT`ZD)&WVZ9%GNK0].?\]+A^/[C2_0&*/R@`L=,X@!>W_")OB.4YNGH($$/8
M.NL@6ZGN7%&UN[9-+BBA#2`LTU;Q7U#UE'8%*U<W!PLN`DZ1$*$=E9JBNV,H
M'6NQ=$HA]X:VUF\GI.0$Y.8/0'"N8;K&O5.L<W^T+5YX5NF>_+H%>@\T60?O
MM)QH7U*[]ICTR8X^H"C^S$BY>.9C^^EE\U9ELKC[B6^<S9,D48*R\>P$E.3S
MHZJ:)Q;Q::BB2#+<("9S)&(!$R!4QS&``KK.;9`;T@8*>?`)B<*.[G>"R:7!
M=/8GJQI""U>;/ERYN-_]0.'6!L:8<P:X756M:ZLZ$<JS5V1:@C\JY;1J$XP5
M,D<*=2H`'76M_EUE;`"8MU=Y7O[._*LB=XNKA_@#B/0?NKB_+V_?-C;?&7/%
MK9NP[@;*&-)[%-U,KKN+'[L6CZ#9&CS&?.`:.;E6,444A,.TR1A+3TT2VV*P
M_F$;V:0[24Q(4Y8!<5]M"]R-VZPD#@XMU@G#+'NPQH6I]VVN/CU]/+:]ZK**
MXZF+^6>31)$Z1X\9>(9`G;[-VX(4&X_*'3!-(*^A0]1KJSNSTW&?0/&2T?W&
M^\U4V>W_`/8L>X>$*?[Q%/14#;2#0M!*H=/84/@3(0VQ(I`#X0+VB@/3[=<R
ME?)"'!'*YY*]]=9M(XI86D)@P#/+#*L7<[5@]MV<:2::"L>YAY-!^1SM!'Y!
M5FL1X)Q,(%V@D;K7V'4]A-,Z^B/B`UCA0W<X86V,WPGP<_XTRBQW.M\7^$GR
MEDQHZ!K'*\N\EVS"C'G*)/T>:N.UFCDC`2B)3C1=40I6M!Z:ZT+2*YW]C+L`
M1_)*-6&*CCAC7.W2O9T\?ECX_G.&."<L>RCSXK>5N[\*<<L%XJLOQM\OY*U[
M,QC;,3#3$!B2\G,'+*M&"8/)-HY96\9NNWE':JSDI@$0-W=P>NAFY=+[9/*Z
M3SFM!.6H(,O3[:O;9N^XQ1A@#L!GI[^RN]O?,_E239NXQ_XT>9JD?(M7#%\D
M?#E]&(HS>)';NDSE_IZIBG14,`A[AJK:]*[/'*U[KAH1P_$.!'.K5SO>\/C<
M(V2+I/X.*'LJU^GZ@<M6QB#E)#Y"PYD/"5JO.14W>6,;3R/;DO:KM*#O5NZ=
M2RC9I+M&*IDR.6R0'$`&@B&JW7L>WNC9%MQC+2T@EK@Y4<TA4)/.I.DG[DZX
M=+N(D#M0/B;I_"Y>`XI3B.G\JE0IVZ5KT_+ZU^S6(3P:>RMVOB7MI'?Z@'_Z
M?N:WY*?T;CZO<4!(H%_UJQIN'>8!`#`6M/M&@:VOT];JZRL0J>-^/_=/K)];
M_P#Y:[[F<%_U6)A33/Z?KRJ<3_'+87(VWN1T[>T?(Y/N?'$O;2EN66^N$KAO
M"L+N0=@Z<-5DTT]H2!``VT`^[70NL.F+C<KULD+VDC#$'BN."\:Y)TQU&W;Q
MXFZ5PP<`B%O,<4IQ3_O._BZZUNG+/X_Z:R?M]G\T-8>Y^GNX:%D+7-[&OKHP
MZ^MFMQ7#];?=24'U(G)3'?+G@QP<Y"8A5DWN-;TS/=YX1U.1:T;(./EK(F-I
MUHXZ@*HD`PUJ(T"FCW15H[;=RFC<5<(V=G$>ZL[UA<_S';HW)@7GM_">7?16
M\:2+$^E_N,H'*0_^C^1]J@AWD5*S#D2*$VB01K[=>GWZ&3/#^NY7'B^3_":+
MP1EG0S&X_#']HH1OI'`I>?+$`*X^*+M95)-1,4TEC?\`0B&'KU`H!T+U]-:/
MZF2_LZNUJ_[-9SZ=0.:YKA\.H\/UUN/U6O#B])M[ACF7:4$]>6]:EKO+`R2O
M&IBZ<PAR2XRMN3KW:FH0L4W(<K<VXH="]3:"?3_>&0%\&H!23F/R^T\Z,=>[
M<^1S)T4@<02/BRP3"B_\5OF=X`9,XYX\Q[R5N?#V'LXX^M.$M*X0R%#6W"V]
M<KJ*8HI)3D/+OT$2O%7K8A3JD`PT,-??4G4FP[I<[@;C:?,>V0JX-)4%`$S1
M#]M4NG+_`&^RLG,W,1Z6M\.H``G42<3BOW5M&??/UX[<;9RQKBS%]EVKFB`N
M&X4X>][WM"T(20AX-NY4!!`L*Y:QRZ,DN=80VC40$*]!T+DZ:WN"VUW1E9)R
M\1[E*\:+6^\[!<71;#'`YN/Y>Q>&%.1;/=PTA;<"\MMFVC822A8Z8AH]HS0C
M$21LJU([9$,U23(DV6[2M3D`H;3#K`W=K<F7SC(3I<>&*BN@V]W8NB%O&QK=
M81%[\J;T9LO&*\:'E;NK.]XN5K?X_<S<*/SS+P@E1@D,V8KCU%HUP[^$J02L
MU$'!(.I=X%`=HCUUNMN8[=]J^4!'G,(]30%!Y*/;6*OC_)K\SNPC<J<!XB4Q
M]%$'X1,9SSC$67>8F2FJR63.:.8[DR2DJ^()I%IC9BX<PV.XL55`*8K`L2S.
MND`%#HKU$>F@/4MSX?Y6S`M'M*$(.P?;1[:+<3O&Y@>$E5[,1GE0]X4NBTL4
M^>SEI$Y>=M86[\QXDL57C_+71M392<7&NUDYZ'@UES(%!<ZH";:F;<:GV:*2
M1/FVIGRQ4:&Z@W/!N/M1:#B=L-\?F&X:RA<4'Q8>S*G$3F9BXMJ:3D'[9DU0
M,<PN7KM%JBFDEN.Y4=**""3=(A`$Y:]1*`#7KK*165Y+<E2XL&*!J\/;BG=6
MJ?N%C':_M:-1_4.?LIKN;EY9')_ZA+!\1C.60F[*PWA'*%HDNE),X0MPW(Z-
M&GN1A#/A44;/U(0PH;SI#3XP"@>_1Y;-UCTFR%^+S.7'L)8<*YQ'=?.]1RS`
M(/E](7D'9T8OC"$P^1?S!$5,GWRY-PR14B)!*GL_IZ\.VJ"@F-W#K%$=P@-`
MVZS_`%-_R-O_`%?=6EZ;_P">E_K#[#2\YTP$4P*4H!W-IC#ZE*0?@`OXCT_;
MK)L36Y<RRMK$\M!I`*X4S!]1!C\$A)N_]E5S'5(H@H!@)\94@!45*`'<H(A2
MM-:FWD`Z<>W(:V_XJPEW"7=2J0N#SZVUK_A[GXJV^6OETQC.298Z]S<L(N\$
M(,"E:OW=NKVHNV!\P1<&.=XW*L/J0/40TS>H'3VT;OP%KF]Q*5+97#8+YS"?
M$L9[P%4>T5USS]PUQ7'XULKM[43D)-E`7ACN9NYE"HK/GB=DQL\U>W'\XDV.
M)_E6D84QC@;IL]=4]EM?EWA@".+"G:!AA_3*KN[3&\RR!_C2CG$#(&*\D\<,
M.79AR0A).Q7./+60AB0Z[4K=HLA%-4W,>X31$2-W*!BB!ZA7=75;=G7GF.75
MYA)/H3#U5/M5E:,0R:0`$QX%2O&@3\S?,/&O'/A)F:U7LDE(Y/RY8UQ6'CRQ
MX]8CZXI9_*QYDWS_`/3FH@Y(QCFRX&%82B4P4T3V&SN9;N)T@?X6EQPX@(GK
M515;?76;+.1L985>!GP7/.@`CN$MU<P/!EPVCL6.%V.<\(P%NY8P\_6`J4@K
M<-MR<AWXA!4I2]O]801`A@H(B`:*7=U''U&X3H(W%@*G+PC/O6A]M9O/3VN`
M8@..`_4GW42G$KSD<?WEILL6\WI4>)W).QB_T_?EOY1(K"6])246B1$\U"S4
MD#,B[.2,01`/B'N;J&I0`K[GL)ED-S;:7P.=B,D/?D>/*I]NW:2UB\B4N#]*
MA4QP2K#D=Y58GE1'SW%GQNMI/,V7+^C7\#)9<B6RXXQQ?!.DP1D+A7N!N4[1
MTZ6;"J5N`JD+4AJ@;VBVO;8;3<H773F-:'X^K!3EQJEN>Y37.W3B(/+RSLYC
M@G90)^+OB-,YJ\1O/+BN=PXEIZ6SEF"WF$TJ)%5)B]89*%=J/&I]O1)U/-S%
M*8!$?CZ#K6]57$%INENZ%S03;Z20>?/U4!V"*YFVA^MKG`7!.78*59\.O,R`
MSAQKM;!]]2#>WN2/&MF.'<MX]EE$65P(R-E$2BX^:;,URIK.&#V,;IAW"DH(
ME'K76-O[2X>YUT%,90D\N'#A1ZUO8[=(WMQQP5.[TX^H4JID')UC8JM&7OK(
MMUV]:-KP;%Z_D966<-V2""#-JJ[4$/F%OYZH)(F$"E$!-3IZZSIM+^68,A<X
M@D9#GSK417^VB$OD:P.`)SQPQ05ROC5RIP]RQQ/$9NQ!-*O[`F)F9MYC*S+0
M(=1\O#J['CQNDL;8JD)B52-00,'VZ?<V5Y#/\N27]PJW97EI=6XN``PG'/*B
MIW$[6[>&SM[NY4*;-M=]:;:4Z_9JLA5.-7.WA0L<WN+%M\V.+.7.+MW3TI;%
MNY9BX*,DIV%(0\G'$@;OMZ[FZC4BATR&,H[MY-,P"8/@..C&P;K_`"3=X=T#
M=7DDE%15:YN:%,^5"M[VX;MM<VWEV@2`8IJ1'!V2A<N=-P0^DMXU=1-R%RJH
M94A@<=QDS,50Q5"';BD7]0#LE1`!`0J;=N]M;Z3ZD"67S'PD]FO_`"USIGTV
MAC^&X'_A?YZ]_NEO&G_Y`9-_\,:?^J:GD^ID4D>@VW_F?Y*3_IR'A/FD!_[/
M_/1S9F\"6&<Q<.^./#R6RK>;.U^.=QSMQPET,FB`3TP>=A'<.9J\`7G;;IMP
M<]RH"?=MVT"M0SUKU:VVO7W@AP>&C3J1$//3BO=6BN.B_F;1MLZY^$DKH[$R
MU47^.O&7CJP/'<_\>3:]IYY8;VUYZVCW6JS3),`C/.5')US-?G#D540,?T!4
MN[[M"7;U_P#..WCRL'.<=*Y:@1FG!>5%V]/ILK=G\X^$-&K3^4C\*\4YUROQ
M@^(#%7C$E<CS&-;\N>\G&1F<:QD/Z@9I-"-$XTZ)B'3!-X[[G<!$``/AVU]1
MU:ZIZH/4'[8A\IJ#\>K)J?E'],*J].]+C8&AIF\XJ2NC2JE?S'^F-*G9)QK9
M.6K*G\<9!@F%R6C=D8XC)R'D6A7#)ZS<E$BB9RF-0IZ#4H^PZRNUW$VUR^=$
MY7JO+L3CA1C=MMCW6/RW$-!YC5Q7F*:N<@OI0\%7Q>$E<&$\Z7)B:&F7ZKE6
MTY.UT;NAFR)AWE:MC$GX`Y$TS"-.G0O3KKI%C]2'6A+I+,/>0!_O$Q''X#6/
MN.@(YV!GS*`$_P"FN?\`;HI.!WTW7%3B%?\`%Y6OVYY3.5_6^9%Q;B<Q'I15
ML1+U$V[YL(,7DJ*QBC^4HKAM'W'5/?/J!=[M$([>'Y<#-'ZE1?TM3.I-KZ"M
M=NE,TDHE)7\"8G^T:<8),VR223=))-)%,@)$3`G\LB8`!03(0!#:F4H4*%>@
M:YOINS<><^=Y8JEO/TUMVV=I&08XVM<W(CA0!^0OQX8E\B6*+5Q1E>1DXIK9
MU]1-\0<U#I$.[;+Q_?1<,.R99(1;2+)4$E**!T)6@^FM%LN].VBX=,8_-:YK
M@BZ<TXH<DY4'Z@V(;Y$V-LODN:6XANKX57B,U]"49..L?0>,+%LW'MK(HL[>
MLBVHNUHENF@">V-AV23%B4``X@04TB&$?6HFT'OI9+[<CN#R@+ETYI@`B^CE
M17;;0;?MC=OU%[VM37EFXDX8\TSX4%_.7QN8(YX1-O.[\_6;2R98BACX_P`J
MVBH2.N^US[P4[:3JM738%OC`@B3J.B^U;E/MDA,O[L3E**B*AY')$]-4]SV:
M'<8P(R(I,,0%5`>T<UI/)MX/LLW&"5K9A\B/(7(V*$S]E:PP;HP9)".$`3^4
MD90LW(G64%$-@G!(M0]M%[CJ&"8ZHX&L=V._RT+M^F)(6Z9+DO;R+4_ZU'7C
MWQ;<>,19QP#FK&"$C::_'O'%VX\MFV6W95CY<+O^4_4+AFW7\M9U,F^5_F'V
M_P`WX?R[>M2?J.:;;CMTS-7[NL.U<"$THG+BOHI1]+1P[@;Z.5%BTZ0SBJZE
MU>Q*[/Q_X:V;Q\SER7SI;ER3LM.<G9RV9^[8N7%-5I$/+7:2+-B6)6(8!!!1
M*35WE$H5&G7IU';CNCMPMXX',#3&$557T)AZZ);;M'\OG?/YFO451$X$<S1D
M*4.4`$PDHH10!#K7:H53;[4KMIH6QVA^O/PI[$HPF"4&$EPOL:1YL07-Y>=F
M_P"N8'%DEBMM!)E3-&*1<I4BCY5;>!Q.FF<0!/9^:AMW2FB3-R++$V88,2"J
M\BN2??0F3:1)??.EY7'!.83->'=0B<S?#]87)7,H<DL6Y?R+QPSPNS093-ZX
MZ72!*?;M4TTDOU2,%5F"SGM$V]T5AH(UIJ>WWET<<<,D8<R-ZYIAR.!JI-L`
MEN3<-E+20,-/+TUWOB3P&;<=\37_`(UR5E^^.1ILHJ/RWO)9+53=%E(R3C@C
MGL61@"JX((+%$PB/<-^:E/?5JZWEL[VF*)K`PJ./B':@P3`CVU.S92P(925P
M/AX>ND_)GP7.<?73,O\`ASS"S5QDM"X)%:3?X\@2)3UK,'2YAW_I+<\I$"Q1
MZT`OQ4#WU?CZAM0P>?:L>Y,R[/\`NFHW[).?]W<N;_9_C7:<2^%'"=IP.39#
M+.2<@9[S+E*T)*SI7+F0EDG<E;3.49`P<KV7%"LLE".`0```W>5$1"NO#U.V
M"=D]K;-:QIQ:'?$/RKIP'/"A\W3%S<L,,EP\`E0=/+LU<:)=E+\??$_PRQ]:
M]\W;-L,.8A&%Q_'W1(M_U&3K*KJF8NI,$SIE123,L(*'J8.E::!7#[O>MT-Y
M%"YH<6DL!U8`:<\.(Y4?@AAVK;193$.T@C4<,R798\TSK9IW#/!;FO%Q61IN
MR\/YHCWC)FJQN19*->O'2!DB.$0$Z;A-8WPK5$IZ"`U#VZW'7F];6X6;V/\`
M)<-0!*@<,`B^V@S[/;KU;H3-CTG20F?:J^Q*Y;R+R)P_\9?&G(]ZVI;U@8_5
M-;,A'VM:-H-F24_=MTN&CE*"A6C1%95TY67?+`6H5[=1'KZ:L;?%>;I?Q^:'
MZ`\$G@$R3U>FJ5^++;["0,>UY<Q!SS&>?W5S?PBX&O##/!Z$E\CLW,+D7.-Z
MWGF^YX1P)_F((;[F%9"(C5B*)IF37:QP$$_3X]WH'OYU/</EW`%Q)T,#?2"5
MJ]TNVV&WF,,:09"[U@57Y@>'?"')/)@Y_P`?7I>G'+D&""*"^1\9N2-"RVPQ
MQ.M,Q(&;E>.E.Y\2@K!4H4IUJ$6W=12V3=$T?FMX*Y,,<,CS]E3W_3\%V[5$
MX1$\FKR[10S1/@LE+ZGXQSS!YP9RY%6?&N6J[6Q5CDMB'="U63.W1?E*_FQ7
M2.4FQ0!*&\HCZ5U>GZKAFC<UMHULA:0':U0I@?A&6=4HNEG1D:K@N8N(T9CE
M\5*J9+X?6I=>);'PUCB2=8FLZPWK)S%-+9:$3(9%F%`;J$(NV^)8/SGJ(FJ/
M30"VW(Q7/S-RWSB<P2BX)FA[Z-NVUHM?EK=WE@#,#M7GZ*+W],_["_1N^?\`
M[I_3/F?^4_ZG\IWZ5_/_`!?CH?J'F:TP54]-$=)T:5Q1%K*&`!*("-`]QU&4
M(QRI/`+2#@*H]M/_`#A^\/\`'3-+.=0>7%^85[MI_P"</WA_CI:6<Z7EQ?F%
M4B(M@44,10HJ&#XP[A1IT&OPUJ'35HODT@$>'NJT*F*DD!2@"H"``&P:E'I]
MW7KI%[ERI+579]JE1_`H:B)4\J1J`$"@[5`VT'=T`?;UK7IKRO*E[9*#M4*`
M=>YU`:@/M6OPTTJ50*D4"@!%B]FH]``HU-T_CK[:5*HBFG[J!3\2_P".E2J4
M$D_X50I[A4H_WUTJ53=M/_G`_>7_`!TJ5>,F4?\`C%0$/;T+TJ'O7KJ5KB/@
M%>J:E!)`!$2G+NKU^,!Z]/:NO2^1,04[J2U4`@>RG_!U&XJ:1KPIE'U4_#\H
M:;7E45$43`&Y4H4&H5,4/8>GJ'MI4JK$)0M"*!Z4`:%,'J'7UTJ50,FD->X<
M*B!@-U`H]?4?7I37K20X$9TJHD1;`/\`+5+6O^<INOX5U,7RIX@4[J]JH"2=
M5=RH"!@'>%2AM#[QKTIKS6[!!EE26O)I)%(`)J@)*`!:"4WPT^'K7KT]]>%S
MEQ&-2ZW885PCD=`X`F\47*PY,2F-&&'WB*2%S.,O2=MQEAHH5-M%\\NQXS@V
M;@PF'8J=0#%'T]-7["YN89P^WC<]X&0!7L5`21V94/OXHYV$3.$8[4^]*;\1
M/BGX!W;,O+HX#>34V$XM\\<N5H'"6>K$RG9:#I90ZCA-A#Q^048UBD0AP*"1
M`H0I0UK(>I+N$-9=[8V2YT_$YK@Y.P:3AQY5C[SIZ"Y=KAW)T,(.32U%[?$,
M>%;UC;QN^-W"V7K-OCEGSZM3D9EYG.MU,<Q?(#.V/H)B6[>ZF9`\'CR6OEZA
M+2XJ=L$T4B&4`0"@#70Z7=MSGF+K.T?%(2,&!Y.66#?;5F/:-MA@T75XR1B9
MO+$S[74XT8-&:23?Y1VDHU^7+V2I&2.B8@D3V';"0YBD0[8%VE+\(%I360FC
MN3=NGE=(&H06%453B5X\*U5J;)L`CM1&2$\32,D'+T&LD"90'X%`W>WH;\>E
M>O32J>J8HF$]47($-4.X&PBFX`&HA03`):_;I4JN!+T$%#U#\`+I4JGZ4^ZG
&]VE2K__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
